---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-119584"
form_type: "8-K"
ticker: "JAGX"
cik: "0001585608"
company_name: "Jaguar Health, Inc."
filed_at: "2022-11-16T23:59:59+00:00"
generated_at: "2026-06-21T17:29:02.510678+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Jaguar Health issues Series F Preferred to SynWorld with 6B votes per share to facilitate reverse stock split

## Summary
- Issued 10 shares of Series F Preferred to SynWorld Technologies for $100 total ($10/share).
- Series F Preferred carries 6 billion votes per share, exercisable only on a proposed reverse stock split.
- Reverse split ratio range: 1-for-3 to 1-for-75; board to set exact ratio before Jan 22, 2024.
- Preferred shares mandate redemption within 3 business days after stockholder vote on reverse split.
- Company will call a special meeting for stockholder approval of the reverse stock split amendment.

## SEC filing metadata
- accession: 0001104659-22-119584
- form_type: 8-K
- ticker: JAGX
- cik: 0001585608
- company_name: Jaguar Health, Inc.
- filed_at: 2022-11-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 5.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1585608/000110465922119584/0001104659-22-119584-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1585608/000110465922119584/tm2229955d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-119584
- JSON: https://secwatch.observer/filing/0001104659-22-119584.json
- Plain text: https://secwatch.observer/filing/0001104659-22-119584.txt

## Key facts
- Governance Changes
  Jaguar Health, Inc.: Filed Certificate of Designation for Series F Preferred Stock, establishing the preferences, rights, and limitations of the new series (effective 2022-11-10).
  - Change: charter amendment
  - Effective: 2022-11-10
  source text: The terms of the Series F Preferred Stock are set forth in a Certificate of Designation of Preferences, Rights and Limitations of Series F Preferred Stock (the “Certificate of Designation”) filed with the Secretary of State of Delaware (the “DE SOS”) and effective on November 10, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1585608/000110465922119584/0001104659-22-119584-index.htm
- Material Agreements
  Jaguar Health, Inc. entered into Securities Purchase Agreement with SynWorld Technologies Corporation valued at $100 (effective 2022-11-11).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: SynWorld Technologies Corporation
  - Value: $100
  - Effective: 2022-11-11
  source text: On November 11, 2022, Jaguar Health, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with SynWorld Technologies Corporation (“SynWorld”), pursuant to which the Company agreed to issue, in a private placement (the “Preferred Issuance Transaction”), an aggregate of ten shares (the “Series F Preferred Shares”) of the Company’s Series F Preferred Stock, par value $0.0001 per share (“Series F Preferred Stock”), at a price per share equal to the Series F Original Issue Price (as defined below) for gross proceeds of $100.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1585608/000110465922119584/0001104659-22-119584-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.